Back to RGEN overview
#
RGEN Repligen
PE ratio, current and historical analysis

## RGEN PE ratio history

### Repligen PE ratio by year

## RGEN average PE ratio chart

## RGEN PE vs peers

## Frequently asked questions

###
What is Repligen's PE ratio?

###
What is the 3-year average PE ratio for Repligen (RGEN)?

###
What is the 5-year average PE ratio for Repligen (RGEN)?

###
What is the highest PE ratio for RGEN?

###
How does the current PE ratio for RGEN compare to its historical average?

###
Why is Repligen's PE ratio so high?

###
How is RGEN's PE ratio calculated (Repligen PE ratio formula)?

The current PE ratio for Repligen stock as of Jun 12, 2024 is 510.25. This is calculated based on the current EPS of $0.28 and the stock price of $142.87 per share. The P/E ratio has increased by 98% from the past four quarters average of 257.5.

How has RGEN's PE ratio performed in the past

The average historical PE ratio of Repligen for the last ten years is 126.41. The current PE ratio of 510.25 is comparable to the historical average. Over the past ten years, RGEN's PE ratio was at its highest in the Mar 2024 quarter at 656.86, when the stock price was $183.92 and the EPS was $0.28. The lowest value was in the Jun 2014 quarter, when it reached 44.69 with a price of $22.79 and an EPS of $0.51.

Average

126.41

Median

107.51

Minimum

44.69

Maximum

656.86

Maximum annual increase: 374.34% in 2023

Maximum annual decrease: -55.54% in 2022

Year | PE ratio | Change |
---|---|---|

2023 | 239.73 | 374.34% |

2022 | 50.54 | -55.54% |

2021 | 113.67 | -32.38% |

2020 | 168.1 | -20.04% |

2019 | 210.23 | 51.47% |

2018 | 138.79 | 183.07% |

2017 | 49.03 | -44.32% |

2016 | 88.06 | -12.85% |

2015 | 101.04 | 27.58% |

2014 | 79.2 | 196.07% |

What is the average PE ratio of RGEN for the past years

RGEN's current P/E ratio is above the 3, 5 and 10-year historical averages.

3-year avg

140.04

5-year avg

154.54

10-year avg

126.41

15-year avg

118.67

What is RGEN's PE ratio compared to its peers

Compared to its peer stocks TMO and GE, RGEN's PE ratio stands higher. Repligen's current PE ratio of 510.25 is comparable to the average of its peer group, which is 48.03.

Stock name | PE ratio | Market cap |
---|---|---|

CRL Charles River Laboratories International Inc | 24.85 | $10.94B |

NBIX Neurocrine Biosciences Inc | 36.14 | $13.71B |

TMO Thermo Fisher Scientific Inc | 36.59 | $218.58B |

GE General Electric Co | 50.39 | $170.42B |

TECH BIO-TECHNE Corp | 60.54 | $12.12B |

BMRN Biomarin Pharmaceutical Inc | 77.28 | $16B |

RGEN Repligen Corp | 449.79 | $7.04B |

NVAX Novavax Inc | N/A | $2.11B |

BMY Bristol Myers Squibb Co | N/A | $84.08B |

PFE Pfizer Inc | N/A | $156.68B |

SGMO Sangamo Therapeutics Inc | N/A | $115.5M |

As of Jun 12, 2024, RGEN stock has a price to earnings ratio of 510.25.

Over the last 3 years, the average price to earnings ratio for RGEN stock is 140.04.

Over the last 5 years, the average price to earnings ratio for RGEN stock is 154.54.

Over the last ten years, the quarterly PE ratio reached a historic high of 656.86 in the Mar 2024 quarter.

The current price to earnings ratio of RGEN is 304% higher than the 10-year historical average.

RGEN's PE ratio of 510.25 is considered high because the company's stock price is trading at a higher multiple of earnings.

The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Jun 12, 2024), Repligen's stock price is $142.87. The earnings per share for the trailing twelve months (TTM) ending Mar 2024 is $0.28. Therefore, Repligen's P/E ratio for today is 510.25. `PE RATIO(510.25) = STOCK PRICE($142.87) / TTM EPS($0.28)`

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.